2021 business outlook:Revenues are expected to be $16.4 - $16.8 billion (2020 actual results include ~$240 million in revenues from generic products in Japan divested on February 1, 2021, along with a manufacturing site)Non-GAAP EPS is expected to be $2.50 - $2.70Free...
Teva Pharmaceuticals USA, announced that the Food and Drug Administration (FDA) has approved an auto-injector device for AJOVY® (fremanezumab-vfrm) injection for migraines. “The approval of the AJOVY auto-injector is another important step forward for Teva and the migraine community,”...
Teva Pharmaceutical Industries Ltd reported third-quarter results that were better than expected by analysts. It also appointed Eli Kalif as Executive Vice President and Chief Financial Officer. Revenues in the third quarter of 2019 were $4,264 million,...
Teva Pharmaceuticals has reached a settlement with Cuyahoga and Summit counties of Ohio to settle claims in the Opioid addiction lawsuit. Under the terms of the settlement, Teva will provide buprenorphine-naloxone (sublingual tablets), known by the brand name Suboxone®, valued at $25...
Foamix Pharmaceuticals Ltd. received U.S. Food and Drug Administration (FDA) approval for its  AMZEEQTM (minocycline) topical foam, 4%. AMZEEQ, provides treatment for inflammatory lesions caused by non-nodular moderate to severe acne vulgaris in adults and pediatric patients (age 9 and older). This...
Teva Pharmaceutical received excellent news today, when it was reported the company had reached a tentative agreement with the State of Ohio for its part in the Opioid crisis. The settlement was for $10 million, a sum much below the expectations of...
Teva, once the flagship company of the Israeli economy, has had more woes than the prophet Job. Despite its many problems, Teva still has a strong core business and hopes that by cutting enough expenses from its operations it can become profitable...
Teva Pharmaceutical has entered into a settlement with the State of Oklahoma over the company's marketing of Opioid drugs. Although Teva has not admitted any wrongdoing, it has agreed to pay a fine of $85 million to settle all outstanding claims against...
Todos Medical Ltd. a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, such as Alzheimer's disease, today announced that it has received approval from the Israeli Ministry of Health (AMAR) to...
Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of Tarceva®1 (erlotinib) tablets, 100 and 150 mg, in the U.S. Erlotinib Tablets are a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung...